GRAL

GRAIL, Inc.

Healthcare›Medical - Diagnostics & Research|NASDAQ Global Market|US

Price

$54.99

Market Cap

$2.26B

Beta

5.21

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+17.18%

EPS Growth (YoY)+82.78%

Revenue CAGR 3Y+0.00%

P/E Ratio0.0

PEG Ratio—

FCF Yield-13.26%

Debt / Equity0.04

Interest Coverage999.0x

No credit card required

Already have an account? Sign in to view the full analysis for GRAL.